LY CHU: Open Payments
NPI 1063063238 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,702 in 62 payments from 21 companies in 2025. Trend: 2023 $1,479 · 2024 $1,674 · 2025 $1,702
Food & beverage: $1,702
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $293 |
| Procept Biorobotics Corporation | 2 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $163 |
| Ferring Pharmaceuticals Inc. | 6 | $159 |
| Janssen Biotech, Inc. | 5 | $125 |
| Astellas Pharma US Inc | 5 | $116 |
| Olympus America Inc. | 2 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| PFIZER INC. | 3 | $80 |
| Antares Pharma, Inc. | 3 | $58 |
Products named: AQUABEAM ROBOTIC SYSTEM, Xtandi, Nubeqa, ADSTILADRIN, ORGOVYX, GEMTESA, ERLEADA, iTIND System.
Industry payments across TX — which companies pay providers there.
